acute lymphoblastic leukemia
Genetic Screens Provide Clues About Prognosis, Risk of Second Cancer
Genetic Screens Provide Clues About Prognosis, Risk of Second Cancer
Shawna Williams | Apr 1, 2018
Mutations in the TP53 gene appear to influence the prognosis and likelihood of future cancers in pediatric leukemia patients.
First CAR T-Cell Therapy Approved in U.S.
First CAR T-Cell Therapy Approved in U.S.
Shawna Williams | Aug 30, 2017
The genetically modified blood cells will be used for patients with a type of acute lymphoblastic leukemia, when other treatments fail.
FDA Votes Yes on CAR T-Cell Therapy
FDA Votes Yes on CAR T-Cell Therapy
Aggie Mika | Jul 13, 2017
A Food and Drug Administration advisory panel unanimously calls for agency approval of the cell therapy for the treatment of resistant leukemia. 
Gene Editing Treats Leukemia
Gene Editing Treats Leukemia
Karen Zusi | Nov 6, 2015
One-year-old Layla Richards has remained cancer-free months after receiving an experimental gene editing therapy.
Tumor-Targeting T Cells Engineered
Tumor-Targeting T Cells Engineered
Chris Palmer | Aug 11, 2013
Scientists genetically modify T cells derived from pluripotent stem cells to attack lymphatic tumors.
Immune System Versus Cancer
Immune System Versus Cancer
Dan Cossins | Apr 10, 2013
Engineering the immune system to overcome tumor evasion strategies was a hot topic at this week’s AACR meeting, with researchers discussing several new approaches.
Leukemia Linked to Changes in Womb
Leukemia Linked to Changes in Womb
Edyta Zielinska | Apr 10, 2013
Genetic changes that may initiate childhood leukemia could originate while the baby is still in utero.
Contributors
Contributors
Kate Yandell | Apr 1, 2013
Meet some of the people featured in the April 2013 issue of The Scientist.
Up, Up, and Array
Up, Up, and Array
Megan Scudellari | Apr 1, 2013
By scrutinizing gene expression profiles instead of individual oncogenes, Todd Golub launched a powerful platform for diagnosing, classifying, and treating cancer.